miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastomaShyamal Dilhan Weeraratne(University of Moratuwa), Yoon Jae Cho(Boston Children's Hospital)Neuro-OncologyDecember 22, 201010.1093/neuonc/noq179Cited by 136SaveCiteExport RISWatch citationsRelated PapersMedulloblastoma exome sequencing uncovers subtype-specific somatic mutations|Nature|2012|770